Repeat Dose Study of the Cancer Chemopreventive Agent Resveratrol in Healthy Volunteers: Safety, Pharmacokinetics, and Effect on the Insulin-like Growth Factor Axis
Phase of Trial: Phase I
Latest Information Update: 08 Oct 2010
At a glance
- Drugs Resveratrol (Primary)
- Indications Cancer
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 31 Jan 2007 New trial record.